Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cocrystal Pharma Inc. COCP

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

COCP ....... Early a.m runner on NR

Now in PB mode.......$1.34 Look for support sub $1.30.....stops save portfolios Cheers !  rate and reply

COCP up in pre-market....on watch

Seems like ever since Feb 2020.....it pops on volume evry few months. Here we go again. ps: I don't chase  Cheers !  rate and reply

RE:RE:Q3 EPS: Pipeline Remains on Track

https://www.cocrystalpharma.com/news/press-releases/detail/115/cocrystal-pharma-reports-2020-financial-results-provides  rate and reply

RE:Q3 EPS: Pipeline Remains on Track

https://www.cocrystalpharma.com/news/press-releases/detail/114/cocrystal-pharma-extends-drug-discovery-collaboration-with  rate and reply

Q3 EPS: Pipeline Remains on Track

Q3 EPS: Pipeline Remains on Track https://www.channelchek.com/news-channel/Cocrystal_Pharma_Inc.__COCP____Q3_EPS_Pipeline_Remains_on_Track  rate and reply

Cocrystal Pharma Provides Update on Influenza A Program

BOTHELL, WA, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), announces promising in vitro and 7-day toxicity data for its influenza A...read more

The Timing of a COVID Vaccine

A little tiff between the FDA and Trump  https://www.channelchek.com/news-channel/The_Timing_of_a_COVID_Vaccine    rate and reply

Strategic decision to discontinue development of pimodivir

The Janssen Pharmaceutical announced a strategic decision to discontinue the development of pimodivir, a Phase 3 clinical asset.  What does it mean? More at: https://www.channelchek.com...read more